• 45 Hits
  • Search Condition : Filter (MeSH = Neoplasms / therapy*)
Species Resource Title
Human and Animal Cells Colon-26(RCB2657) Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells.
Human and Animal Cells RGM1(RCB0876) Near-Infrared Light Irradiation of Porphyrin-Modified Gold Nanoparticles Promotes Cancer-Cell-Specific Cytotoxicity.
Human and Animal Cells THP-1(RCB1189) , LLC(RCB0558) Zn- and Mg- containing tricalcium phosphates-based adjuvants for cancer immunotherapy.
Human and Animal Cells OS-RC-2(RCB0735) The novel CA IX inhibition antibody chKM4927 shows anti-tumor efficacy in vivo.
Human and Animal Cells EL4(RCB1641) Development of effective tumor immunotherapy using a novel dendritic cell-targeting Toll-like receptor ligand.
Human and Animal Cells K562 Improvement of QOL and Immunological Function With Lentinula Edodes Mycelia in Patients Undergoing Cancer Immunotherapy: An Open Pilot Study.
Human and Animal Cells Hep G2(RCB1648) Nrf2-dependent induction of human ABC transporter ABCG2 and heme oxygenase-1 in HepG2 cells by photoactivation of porphyrins: biochemical implications for cancer cell response to photodynamic therapy.
Human and Animal Cells NALM-6(RCB1933) , CCRF-CEM(RCB1980) A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy.
Human and Animal Cells B16F10(RCB2630) Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells.
Human and Animal Cells A431(RCB0202) , RAW 264(RCB0535) Invention of a novel photodynamic therapy for tumors using a photosensitizing PI3K inhibitor.
Human and Animal Cells Colon-26(RCB2657) Tumor growth suppression by the combination of nanobubbles and ultrasound.
Human and Animal Cells NB1RGB(RCB0222) Preferential sensitization of tumor cells to radiation by heat shock protein 90 inhibitor geldanamycin.
Human and Animal Cells NB-1(RCB1953) , SK-N-SH(RCB0426) , 143B/TK^(-)neo^(R)(RCB0701) , Saos-2(RCB0428) , HOS(RCB0992) , LM8(RCB1450) , MC3T3-E1(RCB1126) Plasma-stimulated medium kills TRAIL-resistant human malignant cells by promoting caspase-independent cell death via membrane potential and calcium dynamics modulation.
Human and Animal Cells TT1TKB(RCB1185) A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors.
Human and Animal Cells A549(RCB0098) , HeLa Lipophilic triphenylphosphonium derivatives enhance radiation-induced cell killing via inhibition of mitochondrial energy metabolism in tumor cells.
Human and Animal Cells Ca9-22(RCB1976) , OVK18(RCB1903) , OCUB-M(RCB0881) , NB69(RCB0480) , TE-15(RCB1951) , TE-4(RCB2097) , TGBC11TKB(RCB1148) , MKN1(RCB1003) , MDA-MB-453(RCB1192) , GI-1(RCB0763) , ... Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.
Human and Animal Cells Saos-2(RCB0428) , HCT116(RCB2979) , HFL-III(RCB0523) , HeLa Targeted cancer cell ablation in mice by an α-particle-emitting astatine-211-labeled antibody against major histocompatibility complex class I chain-related protein A and B.
Human and Animal Cells HEV0060 , PC-9(RCB4455) Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy.
Mice RBRC02975 Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
Human and Animal Cells PC-9(RCB4455) Effect of IL-18 on the Expansion and Phenotype of Human Natural Killer Cells: Application to Cancer Immunotherapy.